Charles Schwab Investment Management »

Unicycive Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Unicycive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $257k 55k 4.69

More positions owned by Charles Schwab Investment Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Micron Technology (MU)
Schwab Strategic Tr Fundamental Intl (FNDF)
Eli Lilly & Co. (LLY)
Home Depot (HD)

View all positions for Charles Schwab Investment Management

Top funds holding Unicycive Therapeutics

BlackRock
Nantahala Capital Management
Diadema Partners
Vanguard Capital Management
Octagon Capital Advisors
Susquehanna International
Geode Capital Management
Vivo Capital
Marshall Wace
Caption Management
Logos Global Management
Diametric Capital
J. Goldman & Co
Citadel Advisors
Millennium Management

View all funds holding Unicycive Therapeutics